Representing 33,600,000 Ordinary Shares (Par Value £0.001 Per Share) GW PHARMACEUTICALS PLC UNDERWRITING AGREEMENTGw Pharmaceuticals PLC • July 14th, 2016 • Pharmaceutical preparations • New York
Company FiledJuly 14th, 2016 Industry JurisdictionIntroduction. GW Pharmaceuticals plc, a company incorporated in England and Wales (the “Company”) proposes to issue and sell to the several Underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of 2,800,000 American Depositary Shares (“ADSs” and, such ADSs, the “Firm ADSs”), each representing 12 ordinary shares, par value £0.001 per share, of the Company (the “Ordinary Shares”). The ADSs will be evidenced by American Depositary Receipts (“ADRs”) issued pursuant to that certain Deposit Agreement dated May 7, 2013 (the “Deposit Agreement”), by and among the Company, Citibank, N.A., as depositary (the “Depositary”), and all holders and beneficial owners of ADSs issued thereunder. The Ordinary Shares to be issued in connection with, and represented by, the ADSs are hereinafter referred to as the “Underlying Securities.”
1,700,000 American Depositary Shares Representing 20,400,000 Ordinary Shares (Par Value £0.001 Per Share) GW PHARMACEUTICALS PLC UNDERWRITING AGREEMENTGw Pharmaceuticals PLC • June 20th, 2014 • Pharmaceutical preparations • New York
Company FiledJune 20th, 2014 Industry JurisdictionIntroduction. GW Pharmaceuticals plc, a company incorporated in England and Wales (the “Company”), and certain shareholders of the Company (the “Selling Shareholders”) named in Schedule I hereto severally propose to issue and sell to the several Underwriters named in Schedule II hereto (the “Underwriters”) an aggregate of 1,700,000 American Depositary Shares (“ADSs” and, such ADSs, the “Firm ADSs”), each representing 12 ordinary shares, par value £0.001 per share, of the Company (the “Ordinary Shares”), of which 1,200,000 ADSs are to be issued and sold by the Company and 500,000 ADSs are to be sold by the Selling Shareholders, each Selling Shareholder selling the amount set forth opposite such Selling Shareholder’s name in Schedule I hereto.
American Depositary Shares Representing [_______] Ordinary Shares (Par Value £0.001 Per Share) GW PHARMACEUTICALS PLC UNDERWRITING AGREEMENTGw Pharmaceuticals PLC • January 6th, 2014 • Pharmaceutical preparations • New York
Company FiledJanuary 6th, 2014 Industry JurisdictionThe ADSs will be evidenced by American Depositary Receipts (“ADRs”) issued pursuant to that certain Deposit Agreement dated May 7, 2013 (the “Deposit Agreement”), by and among the Company, Citibank, N.A., as depositary (the “Depositary”), and all holders and beneficial owners of ADSs issued thereunder. The Ordinary Shares to be issued in connection with, and represented by, the ADSs are hereinafter referred to as the “Underlying Securities.”